Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Other2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT04444921Phase 3Active Not Recruiting
EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients
Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaMetastatic Anal Squamous Cell Carcinoma+4 more
PrincipalinvestigatorStart date: 2020-11-17
NCT02560298Phase 2Unknown
Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer
Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Squamous Cell Carcinoma+4 more
PrincipalinvestigatorStart date: 2016-08-23

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Lakshmi Rajdev

ECOG-ACRIN Cancer Research Group

Related
4 trials

Shared therapeutic areas:

Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaStage III Anal Cancer AJCC v8

Worked with same sponsors:

ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)
Similarity Score8%

Michael Kurman, MD

Traws Pharma, Inc.

Related
1 trials

Shared therapeutic areas:

Anal Squamous Cell Carcinoma
Similarity Score3%

Antonio Arrivi, MD

Hospital Son Llatzer

Related
1 trials

Shared therapeutic areas:

Anal Squamous Cell Carcinoma
Similarity Score3%

Eva S Serup-Hansen, MD, PhD

Herlev og Gentofte Hospital

Related
1 trials

Shared therapeutic areas:

Anal Squamous Cell Carcinoma
Similarity Score3%

Carlos Fernández-Martos, MD

Instituto Valenciano de Oncología

Related
1 trials

Shared therapeutic areas:

Anal Squamous Cell Carcinoma
Similarity Score3%

Isabel Sevilla, MD

Hospital Universitario Virgen de la Victoria (Málaga)

Related
1 trials

Shared therapeutic areas:

Anal Squamous Cell Carcinoma
Similarity Score3%

Joan Maurel, MD

Hospital Clinic of Barcelona

Related
3 trials

Shared therapeutic areas:

Anal Squamous Cell Carcinoma
Similarity Score3%

Pilar García-Alfonso, MD

Hospital Universitario Gregorio Marañón (Madrid)

Related
1 trials

Shared therapeutic areas:

Anal Squamous Cell Carcinoma
Similarity Score3%

Fernando Rivera, MD

Hospital Universitario Marqués de Valdecilla (Santander)

Related
1 trials

Shared therapeutic areas:

Anal Squamous Cell Carcinoma
Similarity Score3%

Marta Martín, MD

Hospital de la Santa Creu i Sant Pau de Barcelona

Related
2 trials

Shared therapeutic areas:

Anal Squamous Cell Carcinoma
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04444921Phase 3PrincipalInvestigator

EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients

Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaMetastatic Anal Squamous Cell Carcinoma+4 more
Active Not Recruiting
NCT02560298Phase 2PrincipalInvestigator

Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer

Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Squamous Cell Carcinoma+4 more
Unknown

All 2 trials loaded